Navigation Links
Novogen Announces Establishment of Global Collaboration to Drive The Development of Drugs to Treat Brain Cancer
Date:12/20/2013

Novogen

Novogen Ltd is a public, Australian biotechnology company whose shares trade on both the Australian Securities Exchange ('NRT') and NASDAQ ('NVGN').  The Company is based in Sydney, Australia, and with a US office in New Haven, Connecticut. The Company has two main drug technology platforms known as super-benzopyrans (SBP) and anti-tropomyosins (ATM). SBP drugs target cancer stem cells and are being developed for the treatment of ovarian cancer and glioblastoma. ATM drugs target the cancer cell cytoskeleton and are being developed for the treatment of melanoma, prostate cancer and neuroblastoma. Novogen has entered into a joint venture with Yale University known as CanTx Inc with the aim of developing personalized chemotherapy for patients with ovarian cancer.

Further information is available on the Company's web site, www.novogen.com


'/>"/>
SOURCE Novogen Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Novogen Files Suite of Patents for Anti-Tropomyosin Drug Technology
2. Novogen Launches Joint Venture Aimed At Developing Drugs to Fight Ovarian Cancer
3. A Look Inside, Factors of Health - Research Report on Novogen Limited, Sanofi SA, ISIS Pharmaceuticals, Inc., Amgen, Inc. and Gilead Sciences, Inc.
4. As Released on 30 December, 2011: Novogen Modifies ADR Program and Makes Further Investment Into Marshall Edwards
5. Symphogen Announces the Appointment of Annika Espander Jansson as Non-Executive Director
6. Lineagen Announces $3.5 Million Series C Round and Close of Series B Financing
7. Amgen Announces Positive Top-Line Results From Phase 3 MENDEL-2 Trial Of Evolocumab (AMG 145) In Patients With High Cholesterol
8. Asmacure Announces Clinical Update for ASM-024 DPI in Two Phase 2 Trials
9. China Cord Blood Corporation Announces Results of 2013 Annual General Meeting
10. Synthetic Biologics Announces Exercise of Underwriters Over-Allotment Option
11. Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
(Date:7/28/2015)... SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 28, ... ) today announced its financial results for the ... ®  sales grew nearly 300% as compared to ... was first launched," said Roger Jeffs, Ph.D., United ... in Orenitram sales was due to an increase ...
(Date:7/27/2015)... Tenn. , July 27, 2015  Capella ... care services and one of the largest for-profit ... its parent company and sole stockholder, Capella Holdings, ... Properties Trust, Inc. ("MPT") (NYSE: MPW ) ... The transaction is expected to be finalized during ...
(Date:7/27/2015)... ... July 27, 2015 , ... Brady (NYSE:BRC), ... video: 3 Ways to GHS Labels . This video provides useful information ... System (GHS) by effectively labeling chemical containers. , “With the fourth and final ...
Breaking Biology Technology:Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 2United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 3United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 4United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 5United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 6United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 7United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 8United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 9United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 10United Therapeutics Corporation Reports Second Quarter 2015 Financial Results 11Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 2Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 3Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 4Capella Healthcare Announces Agreement With Medical Properties Trust, Inc. 5Brady Releases “3 Roads to GHS Labels” Video 2
... to Focus on Critical Industry Issues -- DUBAI, UAE, September 8, 2010 ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { ...
... researchers has completed the majority of the genome sequence ... efforts of Virginia Tech faculty members. The research ... Turkey ( Meleagris gallopavo ): Genome Assembly and Analysis" ... of Science) on Sept. 7, 2010. "To date, ...
... YORK, Sept. 7 Reportlinker.com announces that a new ... Proteomics - Technologies, Markets and Companies ... report describes and evaluates the proteomic technologies that will ... and practice of medicine in the post-genomic era - ...
Cached Biology Technology:Cold Chain MENA 2010 to Focus on Critical Industry Issues 2Cold Chain MENA 2010 to Focus on Critical Industry Issues 3Cold Chain MENA 2010 to Focus on Critical Industry Issues 4Cold Chain MENA 2010 to Focus on Critical Industry Issues 5Cold Chain MENA 2010 to Focus on Critical Industry Issues 6Virginia Tech researchers contribute to turkey genome sequencing 2Virginia Tech researchers contribute to turkey genome sequencing 3Reportlinker Adds Proteomics - Technologies, Markets and Companies 2Reportlinker Adds Proteomics - Technologies, Markets and Companies 3Reportlinker Adds Proteomics - Technologies, Markets and Companies 4Reportlinker Adds Proteomics - Technologies, Markets and Companies 5Reportlinker Adds Proteomics - Technologies, Markets and Companies 6Reportlinker Adds Proteomics - Technologies, Markets and Companies 7Reportlinker Adds Proteomics - Technologies, Markets and Companies 8Reportlinker Adds Proteomics - Technologies, Markets and Companies 9Reportlinker Adds Proteomics - Technologies, Markets and Companies 10Reportlinker Adds Proteomics - Technologies, Markets and Companies 11Reportlinker Adds Proteomics - Technologies, Markets and Companies 12Reportlinker Adds Proteomics - Technologies, Markets and Companies 13Reportlinker Adds Proteomics - Technologies, Markets and Companies 14Reportlinker Adds Proteomics - Technologies, Markets and Companies 15Reportlinker Adds Proteomics - Technologies, Markets and Companies 16Reportlinker Adds Proteomics - Technologies, Markets and Companies 17Reportlinker Adds Proteomics - Technologies, Markets and Companies 18Reportlinker Adds Proteomics - Technologies, Markets and Companies 19Reportlinker Adds Proteomics - Technologies, Markets and Companies 20
(Date:7/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) ... Outlook of the Biometrics Industry 2015 " ... global biometrics market is likely to witness significant ... to the uptake of multiple technologies available. The ... the growth of biometrics in existing applications as ...
(Date:7/21/2015)... , July 21, 2015  NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile ... wallet, announces that it has filed provisional patent ... Method. This invention highlights next ... authorizes an account, but also the user using ...
(Date:7/20/2015)... , July 20, 2015  Acuity Market ... Report: The Convergence of Commerce and Privacy" forecasts ... mobile biometric apps will be downloaded to smart ... The mobile biometrics market is projected to generate ... revenue during the seven-year forecast period.    ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... , April 17, 2013 /PRNewswire-iReach/ -- 2013  Infectious ... of Department of Defense (DoD) clinical and research ... challenges facing the military, revealed that it is ... conduct a completely paperless clinical study resulting in ...
... Institute for Natural Resources, (INR) Oregon Biodiversity Information ... last night at the NatureServe network,s annual Biodiversity ... recognizes ORBIC,s leadership in engaging network members in ... ORBIC is one of three members of the ...
... Heritage Program (NCNHP) received the 2013 Scientific and Technical ... Biodiversity Without Boundaries conference in Baltimore. , "This ... achievement of the North Carolina Natural Heritage Program in ... and CEO of NatureServe. "This is the second part ...
Cached Biology News:Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk 2Oregon Biodiversity Information Center wins 2013 Natureserve Network Collaboration Award 2North Carolina Natural Heritage Program earns 2013 Award for Science and Technical Achievement 2
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Dnase and Rnase free...
... Quality 96 Well BAC Prep; ... preparation from 1.5ml 2xYT cultures; ... automated fluorescent sequencing for small ... ProPrep strategy which minimizes shearing ...
Olig2 Immunogen: Synthetic peptide from rat. Available Date: 9-19-2006...
Biology Products: